4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-21-068510
President and CEO bought 42,518 shares at an average $12.44 ($529,102)
From the SEC's structured data for this filing
Trades in this filing
Session R.A. II · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-23 | Purchase : show line 1 in the form | +16,510 | $12.12 | $200,101 | 9,164,912 | D |
| 2021-11-23 | Purchase : show line 2 in the form | +26,008 | $12.65 | $329,001 | 9,190,920 | D |
| Open-market purchases · 42,518 sh · avg $12.44 · $529,102 | ||||||
Loading xslF345X03/doc4.xml…